Novartis AG ADR [NVS] stock is trading at $116.94, up 0.86%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVS shares have gain 4.53% over the last week, with a monthly amount glided 3.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on February 13, 2025, when UBS downgraded its rating to a Neutral. On February 04, 2025, upgrade upgraded it’s rating to Buy. HSBC Securities downgraded its rating to a Reduce. BofA Securities downgraded its rating to a Neutral and reduced its price target to $130 on September 11, 2024. Goldman downgraded its rating to Neutral for this stock on September 05, 2024. In a note dated September 03, 2024, Jefferies downgraded an Hold rating on this stock.
Novartis AG ADR [NVS] stock has fluctuated between $96.06 and $120.92 over the past year. Currently, Wall Street analysts expect the stock to reach $116.33 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $116.94 at the most recent close of the market. An investor can expect a potential drop of -0.52% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Novartis AG ADR [NYSE:NVS] reported sales of 51.72B for the trailing twelve months, which represents a growth of 11.87%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.3%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.31 and Total Capital is 0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Novartis AG ADR’s Current Ratio is 0.79. Also, the Quick Ratio is 0.61, while the Cash Ratio stands at 0.22. Considering the valuation of this stock, the price to sales ratio is 4.29, the price to book ratio is 5.97 and price to earnings (TTM) ratio is 18.31.
Transactions by insiders
Recent insider trading involved Marshall Fiona, Officer, that happened on May 23 ’25 when 15000.0 shares were purchased. Officer, Kowalski Robert William completed a deal on Apr 30 ’25 to buy 1212.0 shares. Meanwhile, Officer Kowalski Robert William bought 6566.0 shares on Aug 12 ’24.
